LD-2 disclosure · 3rd Quarter - Report

C R BARD INC

via C. R. BARD, INC.

3rd Quarter (July 1 - Sep 30) · 2008Posted Oct 20, 2008Filing document ↗LDA record ↗

Expenses$5Kself-filed spend

Client

3 issues

Health Issues
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
LobbyistsHOLLY P GLASS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Consumer Issues/Safety/Products
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
LobbyistsHOLLY P GLASS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.

LD-2 disclosure · 3rd Quarter - Report

via C. R. BARD, INC.

3rd Quarter (July 1 - Sep 30) · 2008Posted Oct 20, 2008Filing document ↗LDA record ↗

Expenses$5Kself-filed spend

3 issues

Health Issues
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
LobbyistsHOLLY P GLASS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Consumer Issues/Safety/Products
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
LobbyistsHOLLY P GLASS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.